BioLargo, Inc. Stock price Other OTC
Equities
BLGO
US09065A1007
Commodity Chemicals
Financials (USD)
Sales 2023 * | 11.71M | Sales 2024 * | 18.52M | Capitalization | 104M |
---|---|---|---|---|---|
Net income 2023 * | -4M | Net income 2024 * | -1M | EV / Sales 2023 * | 8.91 x |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | 5.63 x |
P/E ratio 2023 * |
-17.7
x | P/E ratio 2024 * |
-
| Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 85.64% |
Latest transcript on BioLargo, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Dennis Calvert
CEO | Chief Executive Officer | 61 | 02-05-31 |
Director of Finance/CFO | 68 | 08-01-31 | |
Chief Operating Officer | 55 | 02-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Marshall
BRD | Director/Board Member | 81 | 06-04-27 |
Kenneth Code
CTO | Chief Tech/Sci/R&D Officer | 77 | 07-03-31 |
Dennis Calvert
CEO | Chief Executive Officer | 61 | 02-05-31 |
1st Jan change | Capi. | |
---|---|---|
+9.49% | 109B | |
-6.47% | 61.6B | |
+4.73% | 34.64B | |
+7.57% | 33.41B | |
+10.95% | 31.17B | |
+9.17% | 19.53B | |
+10.61% | 18.93B | |
+6.09% | 15.7B | |
+4.83% | 14.64B |